Atlas Trials

A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer

Clinical trial NCT02259582 · COMPLETED

Trial details

NCT number
NCT02259582
Sponsor
OncoMed Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nonsquamous Nonsmall Cell Neoplasm of Lung
Start date
2015-02-01
Primary completion
2017-04-07
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.